Data / Form D filings / Automera US Inc.
Automera US Inc.: Form D filings
Automera US Inc., a biotechnology company in Seattle, WA, filed 3 Form D notices with the SEC between 2023 and 2026. The latest, on August 7, 2026, reports $1 million sold of a $7 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2815 EASTLAKE AVE E #300, Seattle, WA, 98102
- Phone
- (206) 957-7300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1992812
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | New notice | $7,000,000 | $1,000,000 | $6,000,000 | 3 | Jul 23, 2026 | sec.gov |
| Oct 17, 2024 | Amendment | $20,649,999 | $12,199,998 | $8,450,001 | 12 | Sep 5, 2023 | sec.gov |
| Sep 27, 2023 | New notice | $20,649,999 | $6,950,000 | $13,699,999 | 12 | Sep 5, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thong Le | Executive Officer, Director, Promoter | |
| Mitchell Hymowitz | Executive Officer | |
| Suzanne Rettenmier | Executive Officer | |
| Yu-Chieh Alice Chen | Director | |
| Benjamin Zian-Loong Wang | Director | |
| Sean Cassidy | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Aug 3, 2026 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Automera US Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.